Table 1 Baseline characteristics of subjects in 1st, 2nd and validation cohort
1st Screening | 2nd Screening | Validation | |||
|---|---|---|---|---|---|
Patients (n = 10) | Patients (n = 134) | HD (n = 24) | Patients (n = 70) | HD (n = 42) | |
Age | 72.4 (3.53) | 68.1 (10.4) | 64.4 (8.03) | 68.6 (10.3) | 53.0 (4.57) |
Male gender | 9 (90) | 106 (79.3) | 21 (87.5) | 54 (77.1) | 25 (59.5) |
Hypertension | 6 (60) | 88 (65.9) | 1 (4.17) | 45 (64.3) | N/A |
Diabetes | 3 (30) | 35 (25.9) | 3 (12.5) | 17 (24.3) | N/A |
Hyperlipidemia | 3 (30) | 36 (26.7) | 1 (4.17) | 22 (31.4) | N/A |
Smoking | 1 (10) | 46 (34.1) | 6 (25.0) | 24 (34.3) | N/A |
Stroke | 10 (100) | 129 (96.3) | 0 (0) | 67 (95.7) | 0 |
Stroke etiology | - | - | |||
LAA | 10 (100) | 34 (21.5) | 29 (41.4) | ||
SVD | 0 (0) | 62 (39.2) | 18 (25.7)4 | ||
CE | 0 (0) | 14 (8.9) | (5.71) | ||
UD and others | 0 (0) | 24 (15.2) | 16 (23.9) | ||
Carotid stenosis >50% | 10 (100) | 31/102 (30.4) | N/A | 38/60 (63.3) | N/A |